TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 27 filers reported holding TRINITY BIOTECH PLC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,697,000 | +6.8% | 1,543,115 | 0.0% | 0.16% | +48.6% |
| Q4 2019 | $1,589,000 | -14.9% | 1,543,115 | 0.0% | 0.11% | -19.6% |
| Q3 2019 | $1,867,000 | -34.6% | 1,543,115 | 0.0% | 0.14% | -36.4% |
| Q2 2019 | $2,855,000 | -36.8% | 1,543,115 | -2.6% | 0.22% | -36.9% |
| Q1 2019 | $4,514,000 | +24.5% | 1,583,846 | 0.0% | 0.34% | +11.0% |
| Q4 2018 | $3,627,000 | -44.7% | 1,583,846 | -3.4% | 0.31% | -31.3% |
| Q3 2018 | $6,557,000 | -20.0% | 1,639,296 | 0.0% | 0.45% | -18.6% |
| Q2 2018 | $8,196,000 | -2.9% | 1,639,296 | 0.0% | 0.55% | -9.3% |
| Q1 2018 | $8,442,000 | +1.0% | 1,639,296 | 0.0% | 0.61% | -0.2% |
| Q4 2017 | $8,360,000 | -9.1% | 1,639,296 | 0.0% | 0.61% | -11.3% |
| Q3 2017 | $9,196,000 | -6.5% | 1,639,296 | 0.0% | 0.69% | -11.7% |
| Q2 2017 | $9,836,000 | +1.5% | 1,639,296 | +0.8% | 0.78% | -3.3% |
| Q1 2017 | $9,694,000 | -13.9% | 1,626,496 | 0.0% | 0.81% | -24.3% |
| Q4 2016 | $11,255,000 | -47.7% | 1,626,496 | 0.0% | 1.07% | -56.2% |
| Q3 2016 | $21,502,000 | +16.6% | 1,626,496 | 0.0% | 2.44% | +10.6% |
| Q2 2016 | $18,444,000 | +10.2% | 1,626,496 | +13.3% | 2.21% | -1.2% |
| Q1 2016 | $16,741,000 | +3.7% | 1,435,724 | +4.5% | 2.23% | -3.3% |
| Q4 2015 | $16,151,000 | +42.3% | 1,373,357 | +38.4% | 2.31% | +11.6% |
| Q3 2015 | $11,351,000 | -22.0% | 992,235 | +23.1% | 2.07% | -15.2% |
| Q2 2015 | $14,556,000 | +29.5% | 805,983 | +38.0% | 2.44% | +3.7% |
| Q1 2015 | $11,242,000 | +18.2% | 584,024 | +7.3% | 2.36% | +14.5% |
| Q4 2014 | $9,511,000 | +49.3% | 544,112 | +56.0% | 2.06% | +24.1% |
| Q3 2014 | $6,370,000 | +15.7% | 348,686 | +45.8% | 1.66% | +1.1% |
| Q2 2014 | $5,507,000 | -2.1% | 239,138 | +3.0% | 1.64% | -8.9% |
| Q1 2014 | $5,626,000 | -6.5% | 232,175 | -3.1% | 1.80% | -7.2% |
| Q4 2013 | $6,014,000 | – | 239,495 | – | 1.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prospect Capital Advisors, LLC | 336,550 | $3,924,000 | 4.65% |
| ACK Asset Management | 979,600 | $11,422,000 | 4.49% |
| Balter Liquid Alternatives, LLC | 161,284 | $1,881,000 | 4.33% |
| GOLDMAN CAPITAL MANAGEMENT INC | 396,690 | $4,625,000 | 3.50% |
| Paradice Investment Management LLC | 1,435,724 | $16,741,000 | 2.23% |
| Adirondack Research & Management Inc. | 415,353 | $4,843,000 | 1.76% |
| Lapides Asset Management, LLC | 705,100 | $8,221,000 | 1.47% |
| Park West Asset Management LLC | 900,000 | $10,494,000 | 0.99% |
| Benchmark Capital Advisors | 83,541 | $974,000 | 0.86% |
| HEARTLAND ADVISORS INC | 1,290,010 | $15,042,000 | 0.79% |